GLUE
Monte Rosa Therapeutics Inc.
$18.05
+$0.93(+5.43%)
48
Overall
60
Value
58
Tech
28
Quality
Market Cap
$812.02M
Volume
870.68K
52W Range
$3.50 - $25.77
Target Price
$32.17
EPS Estimates Overview
| Current Quarter | $-0.28 | Next Quarter | $-0.27 |
| Current Year | $-1.13 | Next Year | $-1.19 |
| QoQ Growth | +3.6% | YoY Growth | -5.3% |
| 3Y EPS CAGR | +30.8% | Target Price | $32.17 |
| Consensus | Buy | Upside | +78.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GLUE | $18.05 | +5.4% | 870.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Monte Rosa Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW